Latest Breaking News On - Darrin beaupre - Page 4 : vimarsana.com

IDEAYA Biosciences (IDYA) Granted FDA Fast Track Designation for IDE161

IDEAYA Biosciences (IDYA) Granted FDA Fast Track Designation for IDE161
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomDarrin beaupreUniversity of manchesterCancer research united kingdomDrug administrationIdeaya biosciences incFast trackChief medical officerNew drug application

IDEAYA Receives Fast Track Designation for Potential First-in-Class PARG Inhibitor, IDE161, for Treatment of Pretreated, Platinum-Resistant Advanced or Metastatic Ovarian Cancer Patients having tumors with BRCA1/2 Mutations

Fast Track designation granted by U.S. FDA for evaluation of IDE161 in adult patients with BRCA1/2 mutant advanced or metastatic ovarian cancer who are platinum resistant and have received prior.

United kingdomDarrin beaupreDrug administrationBiosciences incCancer research united kingdomUniversity of manchesterExchange commissionFast trackChief medical officerNew drug application

IDEAYA Biosciences (IDYA) Granted FDA Fast Track Designation for IDE161

United kingdomDarrin beaupreDrug administrationUniversity of manchesterCancer research united kingdomIdeaya biosciences incFast trackChief medical officerNew drug application

FDA Grants Fast Track Designation to IDE161 for BRCA+, Platinum-Resistant Advanced Ovarian Cancer

The FDA has granted fast track designation to IDE161 for the treatment of adult patients with advanced or metastatic ovarian cancer harboring germline or somatic BRCA1/2 mutations who are platinum resistant and have received prior treatment with antiangiogenic and PARP inhibitor therapies.

Darrin beaupreAccessed septemberPatients with advanced or metastatic ovarian cancer

IDEAYA Biosciences (IDYA) Announces First-Patient-In for Company-Sponsored Phase 2 Trial of Darovasertib

IDEAYA Biosciences (IDYA) Announces First-Patient-In for Company-Sponsored Phase 2 Trial of Darovasertib
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesGrand rapidsAnthony joshuaSreenivasar chandanaDarrin beaupreIdeaya biosciences incExchange commissionCancer hematology centersAlfred healthKinghorn cancer centreHead department of medical oncologyBiosciences incChief medical officerMedical oncologistHematology centers